Experiment 561354
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | FERRY,DR: SMITH,A: MALKHANDI,J: FYFE,DW: DE TAKATS,PG: ANDERSON,D: BAKER,J: KERR,DJ:. (1996). PHASE I CLINICAL TRIAL OF THE FLAVONOID QUERCETIN: PHARMACOKINETICS AND EVIDENCE FOR IN VIVO TYROSINE KINASE INHIBITION.. 2(4) |
| Amount utilized | |
| Compound isolated | |
| Disease | PHARMACOKINETICS DESCRIBED BY FIRST-ORDER TWO COMPARTMENT MODEL WITH MEDIAN T1/2 ALPHA AND BETA OF 6 AND 43 MIN, RESPECTIVELY. MEDIAN CLEARANCE 0.28 LITER/MIN/M2. DOSING RANGED FROM 60-170 MG/M2. |
| Dose amount | VAR |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |